ReviewThe Lancet. Infectious diseases2020
Need for sustainable biobanking networks for COVID-19 and other diseases of epidemic potential.
Review in The Lancet. Infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed, 51 citations in OpenAlex.
- Translational opportunities in aptamer and nanobody lateral flow assays within the WHO REASSURED framework.Sensors & diagnostics · 2026Review
- Precision oncology without borders: the role of biobanking in integrating Africa's genetic diversity into global genomic research.NPJ precision oncology · 2026Review
- Disease outbreak preparedness: a baseline assessment of infection prevention and control practice in healthcare facilities in Lagos, Nigeria.BMJ public health · 2026Article
- FIND integrated biobanks: A network model for efficiency and preparedness based on equitable partnership contracts.Journal of clinical and translational science · 2026Article
- Design, creation, and use of the Test Us Bank (TUB) COVID-19 sample biorepository.BMC infectious diseases · 2024Article
- The Importance and Challenges of Implementing and Maintaining Biorepositories for High-Consequence Veterinary and One Health Pathogens in South-East Asia.Applied biosafety : journal of the American Biological Safety Association · 2024Article
- Biobanks and data interoperability in Latin America: engendering high-quality evidence for the global research ecosystem.Frontiers in medicine · 2024Review
- Understanding the value of biobank attributes to researchers using a conjoint experiment.Scientific reports · 2023Article
- UPO Biobank: The Challenge of Integrating Biobanking into the Academic Environment to Support Translational Research.Journal of personalized medicine · 2023Article
- Specimen sharing for epidemic preparedness: Building a virtual biorepository system from local governance to global partnerships.PLOS global public health · 2023Article
- Access and benefit-sharing of the pathogenic microorganisms such as SARS-CoV-2.Biosafety and health · 2022Review
- Challenges and Opportunities for Global Genomic Surveillance Strategies in the COVID-19 Era.Viruses · 2022Review
- The effects of COVID-19 transmission on environmental sustainability and human health: Paving the way to ensure its sustainable management.The Science of the total environment · 2022Review
- Evaluation of Zika rapid tests as aids for clinical diagnosis and epidemic preparedness.EClinicalMedicine · 2022Article
- Access and benefit-sharing by the European Virus Archive in response to COVID-19.The Lancet. Microbe · 2022Review
- Enlightenment from the COVID-19 Pandemic: The Roles of Environmental Factors in Future Public Health Emergency Response.Engineering (Beijing, China) · 2022Article
- The legacy of ZikaPLAN: a transnational research consortium addressing Zika.Global health action · 2021Review
- Microbial occurrence in liquid nitrogen storage tanks: a challenge for cryobanking?Applied microbiology and biotechnology · 2021Review
- Loop-Mediated Isothermal Amplification Detection of SARS-CoV-2 and Myriad Other Applications.Journal of biomolecular techniques : JBT · 2021Review
- Genomic-informed pathogen surveillance in Africa: opportunities and challenges.The Lancet. Infectious diseases · 2021Review
Corrections and comments
- Commented on by
Authors and funding
5 authors at 4 institutions in 4 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Outbreaks of infectious diseases are occurring with increasing frequency and unpredictability. The rapid development and deployment of diagnostics that can accurately and quickly identify pathogens as part of epidemic preparedness is needed now for the COVID-19 pandemic. WHO has developed a global research and innovation forum to facilitate, accelerate, and deepen research collaboration among countries and funders. Great progress has been made in the past decade, but access to specimens remains a major barrier for the development and evaluation of needed quality diagnostics. We present a sustainable model for a global network of country-owned biobanks with standardised methods for collection, characterisation, and archiving of specimens and pathogens to facilitate and accelerate diagnostics development and evaluation for COVID-19 and other diseases of epidemic potential. The biobanking network should be run on the guiding principles of transparency, equitable access, ethics, and respect for national laws that support country ownership and sustainability. Adapting the Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits, sharing of specimens from national biobanks can be rewarded through mechanisms such as equitable access to diagnostics at negotiated prices. Such networks should be prepared for any pathogen of epidemic potential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.